BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu JF, Klyuzhin I, McKenzie J, Neilson N, Shahinfard E, Dinelle K, McKeown MJ, Stoessl AJ, Sossi V. Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations. Neuroimage Clin 2019;23:101856. [PMID: 31091502 DOI: 10.1016/j.nicl.2019.101856] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Prange S, Theis H, Banwinkler M, van Eimeren T. Molecular Imaging in Parkinsonian Disorders—What’s New and Hot? Brain Sciences 2022;12:1146. [DOI: 10.3390/brainsci12091146] [Reference Citation Analysis]
2 Hsiao IT, Chang YT, Weng YH, Hsu SW, Lin KJ, Lu CS, Chang CC. Comparisons of vesicular monoamine transporter type 2 signals in Parkinson's disease and parkinsonism secondary to carbon monoxide poisoning. Neurotoxicology 2021;88:178-86. [PMID: 34774656 DOI: 10.1016/j.neuro.2021.11.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hinkle JT, Mills KA, Perepezko K, Pontone GM. Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease. J Geriatr Psychiatry Neurol 2021;:891988721996802. [PMID: 33622073 DOI: 10.1177/0891988721996802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhou Y, Tinaz S, Tagare HD. Robust Bayesian Analysis of Early-Stage Parkinson's Disease Progression Using DaTscan Images. IEEE Trans Med Imaging 2021;40:549-61. [PMID: 33055025 DOI: 10.1109/TMI.2020.3031478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zhou XY, Lu JY, Zuo CT, Wang J, Sun YM. Juvenile-onset hypokinetic-rigid Huntington's disease: a case with dual-tracer positron emission tomography. Quant Imaging Med Surg 2021;11:479-82. [PMID: 33392046 DOI: 10.21037/qims-19-992] [Reference Citation Analysis]
6 Tang J, Xu Y, Liu C, Fang Y, Cao S, Zhao C, Huang H, Zou M, Chen Z. PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data. Nuclear Medicine and Biology 2020;90-91:1-9. [DOI: 10.1016/j.nucmedbio.2020.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Fu JF, Matarazzo M, McKenzie J, Neilson N, Vafai N, Dinelle K, Felicio AC, McKeown MJ, Stoessl AJ, Sossi V. Serotonergic System Impacts Levodopa Response in Early Parkinson's and Future Risk of Dyskinesia. Mov Disord 2021;36:389-97. [PMID: 33090574 DOI: 10.1002/mds.28340] [Reference Citation Analysis]
8 Kerstens VS, Varrone A. Dopamine transporter imaging in neurodegenerative movement disorders: PET vs. SPECT. Clin Transl Imaging 2020;8:349-56. [DOI: 10.1007/s40336-020-00386-w] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Goldstein DS, Isonaka R, Holmes C, Ding YS, Sharabi Y. Cardiac sympathetic innervation and vesicular storage in pure autonomic failure. Ann Clin Transl Neurol 2020;7:1908-18. [PMID: 32945121 DOI: 10.1002/acn3.51184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kong Y, Zhou H, Feng H, Zhuang J, Wen T, Zhang C, Sun B, Wang J, Guan Y. Elucidating the Relationship Between Diabetes Mellitus and Parkinson's Disease Using 18F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2. Front Neurosci 2020;14:682. [PMID: 32760240 DOI: 10.3389/fnins.2020.00682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Merola A, Van Laar A, Lonser R, Bankiewicz K. Gene therapy for Parkinson’s disease: contemporary practice and emerging concepts. Expert Review of Neurotherapeutics 2020;20:577-90. [DOI: 10.1080/14737175.2020.1763794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Hu C, Tao L, Cao X, Chen L. The solute carrier transporters and the brain: Physiological and pharmacological implications. Asian J Pharm Sci 2020;15:131-44. [PMID: 32373195 DOI: 10.1016/j.ajps.2019.09.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]